Kazushige Nirei

Itabashi, 1738610, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma.

Journal: Cancers

Published: May 10, 2022

COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.

COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report.

Journal: In vivo (Athens, Greece)

Published: March 20, 2022

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.

No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.

Journal: Global health & medicine

Published: March 18, 2022

Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.

Left Gastric Vein Width Is an Important Risk Factor for Exacerbation of Esophageal Varices Post Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Varices in Cirrhotic Patients.

Journal: Medicina (Kaunas, Lithuania)

Published: December 04, 2021

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.

Efficacy of Glecaprevir/Pibrentasvir for Real-World HCV Infected Patients in the Northern Part of Tokyo, Japan.

Journal: Journal of clinical medicine

Published: November 09, 2021

Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.

Immune Checkpoint Inhibitor as a Therapeutic Choice for Double Cancer: A Case Series.

Journal: Anticancer research

Published: September 08, 2021

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients.

Follow-Up of Patients Who Achieved Sustained Virologic Response after Interferon-Free Treatment against Hepatitis C Virus: Focus on Older Patients.

Journal: Medicina (Kaunas, Lithuania)

Published: June 29, 2021

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.

Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.

Journal: Internal medicine (Tokyo, Japan)

Published: February 01, 2021

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.

Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 11, 2021

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan.

Male-Dominant Hepatitis A Outbreak Observed among Non-HIV-Infected Persons in the Northern Part of Tokyo, Japan.

Journal: Viruses

Published: January 07, 2021

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease.

Journal: International journal of molecular sciences

Published: August 10, 2020

Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells.

Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells.

Journal: Anticancer research

Published: June 04, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026